Fig. 4

hsa_circ_0090081 combines with EIF4A33 to exert its malignant properties in GC. Cell viability, proliferation, migration, and invasion of AGS and HGC-27 cells treated with EIF4A33 overexpression (EIF4A33), oe-NC, sh-hsa_circ_0090081-1 (sh-circ-1), or sh-NC were revealed using A CCK-8, B EdU, C Transwell migration, and D Transwell invasion assays, respectively. **P < 0.001 vs. sh-NC; #P0.05, ##P < 0.001 vs. sh-circ-1 + oe-NC